Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer. This evidence concerns the gene EGFR and thyroid gland undifferentiated (anaplastic) carcinoma.